Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Narrative)

v3.24.1
Commitments and Contingencies (Details Narrative) - USD ($)
 10 Months Ended 12 Months Ended
Feb. 14, 2024
Feb. 13, 2024
Oct. 11, 2023
Dec. 14, 2024
Dec. 31, 2023
Dec. 31, 2022
Loss Contingencies [Line Items]            
Notice deficiency description     On October 11, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days between August 29, 2023, to October 10, 2023, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 8, 2024 (the “Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).      
Reverse Stock Split       1-for-30    
Stock Issued During Period, Shares, Reverse Stock Splits 16,666,666 500,000,000        
Common stock, shares authorized 66,666,666 550,000,000     16,666,666 16,666,666
Common Stock [Member]            
Loss Contingencies [Line Items]            
Reverse Stock Split       one-for-thirty    
Stock Issued During Period, Shares, Reverse Stock Splits         65,960  
Research and Development Expense [Member]            
Loss Contingencies [Line Items]            
Cost and expenses incurred         $ 0 $ 148,000